Skip to content
buyModerate cluster of 2

James A Schoeneck bought $105k of KYNB

director at KYNTRA BIO, INC.. 300,000 shares at an average of $0.35, traded Mar 20, 2025, filed Mar 24, 2025.

Conviction score
43
Value
$105k
300,000 shares
Holdings after
373,722
+407% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $105k at market
    +10
  • Relative to holdings
    Holdings up 407%
    +10
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -16.8%, 3m -41.5%, 6m +32.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

KYNBOct 9, 2026 · close 6.11
Since filing Mar 24, 2025: -33.8%SPY +37.9% · excess -71.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-25-008823, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 20, 2025POpen-market purchase
Common Stockindirect: By Trust
+250,000$0.35$88k323,722Mar 24, 2025
Mar 21, 2025POpen-market purchase
Common Stockindirect: By Trust
+50,000$0.34$17k373,722Mar 24, 2025

Related signals

Other insiders at KYNTRA BIO, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
36Weak
KYNBbuy
KYNTRA BIO, INC.
Thane Wettig
CEO
$20k
2,800 shares
+11%
42Moderate
KYNBbuy
KYNTRA BIO, INC.
Thane Wettig
CEO
$34k
3,700 shares
+17%
53Moderate
KYNBbuy
KYNTRA BIO, INC.
James A Schoeneck
director
$119k
23,567 shares
+146%
46Moderate
KYNBbuy 2
KYNTRA BIO, INC.
Thane Wettig
CEO
$51k
145,000 shares
+36%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.